Use of Insulin Glargine to Treat Diabetic Ketoacidosis
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of the addition of insulin glargine
during the early phase of moderate to severe Diabetic Ketoacidosis (DKA) in children.
The investigators hypothesize that the addition of insulin glargine during the early phase of
management of DKA will accelerate acidosis correction, decrease the length of insulin
infusion, and decrease the total intensive care unit time in children admitted to the ICU.